메뉴 건너뛰기




Volumn 45, Issue 4, 2005, Pages 286-289

Addition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertension

Author keywords

Beraprost; Pulmonary hypertension; Sildenafil

Indexed keywords

BERAPROST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN DERIVATIVE; SILDENAFIL;

EID: 15744382057     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000155386.49103.ce     Document Type: Article
Times cited : (31)

References (9)
  • 1
    • 0023615359 scopus 로고
    • Primary pulmonary hypertension: A national prospective study
    • Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med. 1987;107:216-223.
    • (1987) Ann Intern Med , vol.107 , pp. 216-223
    • Rich, S.1    Dantzker, D.R.2    Ayres, S.M.3
  • 2
    • 3042686863 scopus 로고    scopus 로고
    • Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension
    • Nagaya N, Uematsu M, Okano Y, et al. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension. J Am Coll Cardiol. 1999;34:1188-1192.
    • (1999) J Am Coll Cardiol , vol.34 , pp. 1188-1192
    • Nagaya, N.1    Uematsu, M.2    Okano, Y.3
  • 3
    • 0038037766 scopus 로고    scopus 로고
    • Beraprost therapy for pulmonary arterial hypertension
    • Barst RJ, McGoon M. McLaughlin V, et al. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2003;41:2119-2125.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 2119-2125
    • Barst, R.J.1    McGoon, M.2    McLaughlin, V.3
  • 4
    • 0037152092 scopus 로고    scopus 로고
    • Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial
    • Ghofrani HA, Wiedemann R, Rose F, et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet. 2002;360:895-900.
    • (2002) Lancet , vol.360 , pp. 895-900
    • Ghofrani, H.A.1    Wiedemann, R.2    Rose, F.3
  • 5
    • 1842530387 scopus 로고    scopus 로고
    • Clinical efficacy of sildenafil in primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover study
    • Sastry BK, Narasimhan C, Reddy NK, et al. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol. 2004;43:1149-1153.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 1149-1153
    • Sastry, B.K.1    Narasimhan, C.2    Reddy, N.K.3
  • 6
    • 1242276105 scopus 로고    scopus 로고
    • A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats
    • Itoh T, Nagaya N, Fujii T, et al. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med. 2004;169:34-38.
    • (2004) Am J Respir Crit Care Med , vol.169 , pp. 34-38
    • Itoh, T.1    Nagaya, N.2    Fujii, T.3
  • 7
    • 0037006966 scopus 로고    scopus 로고
    • Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension
    • Ghofrani HA, Wiedemann R, Rose F, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med. 2002;136:515-522.
    • (2002) Ann Intern Med , vol.136 , pp. 515-522
    • Ghofrani, H.A.1    Wiedemann, R.2    Rose, F.3
  • 8
    • 0037389118 scopus 로고    scopus 로고
    • Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension
    • Stiebellehner L, Petkov V, Vonbank K, et al. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Chest. 2003;123:1293-1295.
    • (2003) Chest , vol.123 , pp. 1293-1295
    • Stiebellehner, L.1    Petkov, V.2    Vonbank, K.3
  • 9
    • 0029891069 scopus 로고    scopus 로고
    • A dose-effect study of beraprost sodium in intermittent claudication
    • Lievre M, Azoulay S, Lion L, et al. A dose-effect study of beraprost sodium in intermittent claudication. J Cardiovasc Pharmacol. 1996;27:788-793.
    • (1996) J Cardiovasc Pharmacol , vol.27 , pp. 788-793
    • Lievre, M.1    Azoulay, S.2    Lion, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.